Marijuana Business News

Synonyms: 
stocks
business
Wed
20
Mar

Canadian marijuana stock powers higher on financing

A financing arrangement with a Big Canadian bank boosted a Canadian marijuana stock Tuesday. Here’s some small stocks making big moves on Tuesday, March 19, 2019 (as of 11:30 am EST):

Eve & Co Incorporated (TSXV:EVE), a Canadian marijuana stock, jumped 13% to $0.51 on Tuesday after announcing that it has entered into an $18.7 million construction facility with Royal Bank of Canada to fund the completion of the 780,000 sq. ft. expansion of Eve & Co’s greenhouse production facility located in Middlesex County, Ontario.

Wed
20
Mar

3 marijuana stocks to watch this spring

The cannabis stock sector is currently the hottest sector, and you can make big money by buying pot stocks.

However, while there are many companies that are trading publicly to choose from, you should be careful, because not all of them will survive in the long term.

To help you in your choice, I’m presenting three promising pot stocks that could boom in the coming months.

Wed
20
Mar

New Brunswick companies eager to bite into cannabis edibles market

The owner of Thunder Hill Bakery in Grand Bay-Westfield is planning a reinvention of her signature cupcakes and muffins — with a cannabis twist.  

Jenn Guimond plans to open a second business, one that will showcase recipes using marijuana extracts that she makes at home.

Her new line of baked goods will include both the non-psychoactive CBD oil as well as THC, which does cause the "high." 

Sometimes she takes her cooking classes on the road and teaches neighbours what they can legally do in their own kitchens with their own pot.  

She says most of the interest is coming from people over 65. 

"It's other people's grandmothers," said Guimond, icing a tray of sugar-free, gluten-free, keto-friendly vanilla bean cupcakes infused with CBD. 

Wed
20
Mar

HEXO (TSX:HEXO) is now a top marijuana stock

The marijuana industry is in the midst of an impressive comeback. After crashing post-legalization, the Canadian Marijuana Index is now up 53% year to date. One company that has been making headlines for all the right reasons is HEXO (TSX:HEXO).

In 2019, the company has surged almost 90% and is among the big winners of the year. In the past week alone, the company’s share price has jumped almost 10%. Why? It has been a transformative week for the company.

Prior to releasing strong second-quarter results, the company announced a deal to acquire Newstrike Brands.

Wed
20
Mar

A detailed look at how Aurora Cannabis can produce 700,000 kilograms a year

The marijuana industry is growing like a weed. According to various Wall Street prognostications, the global cannabis industry could be generating upwards of $50 billion to $75 billion in annual sales roughly one decade from now. That's a boatload of cash, and all the more reason for pot growers to double down on capacity expansion.

Although there are 11 growers that are currently on pace for more than 100,000 kilograms in peak annual output, according to their respective management teams, none stands out more than Alberta-based Aurora Cannabis (NYSE:ACB).

Wed
20
Mar

4 Canadian cannabis stocks with significant inventory positions

Inventory turnover is a measure of how efficiently a Company can control its inventory. High turnover is seen as positive by investors as the company does not have much of its working capital tied up in stock.

Canadian LPs need to pass a quality control tests by Health Canada, which requires a third-party lab to test the cannabis to ensure that it is free of contaminates, such as mold, mildew, chemicals, and pesticides before the cannabis can added to inventory. Typically, dried flower has a shelf life of one year, and extracts are longer. Today we have identified four Canadian cannabis stocks with significant inventory positions.

Tue
19
Mar

Zenabis now licensed to sell cannabis oil

Zenabis Global Inc. (“Zenabis”)(TSXV:ZENA) announced today that it is now licensed to process and sell cannabis oil products in Canada. The license enables Zenabis to now sell cannabis oil produced at its Atholville, New Brunswick facility, one of the largest indoor cannabis growing facilities in Canada, where Zenabis was already processing oil.

Zenabis expects to market and sell cannabis oil products to its medical clients and to adult use consumers through supply and distribution agreements that Zenabis has in place with nine Canadian jurisdictions including British Columbia, Alberta, Saskatchewan, Quebec, Nova Scotia, New Brunswick, Manitoba, Prince Edward Island, and the Yukon.

Tue
19
Mar

Cannabis stocks rally ahead of Tilray earnings

Cannabis stocks were higher Monday, as investors reacted to the latest tie-ups in the sector and awaited the release of quarterly earnings from Tilray Inc. after the close.

Tilray shares TLRY, -0.36%  were up 0.8%, ahead of the company’s fourth-quarter earnings, which are expected to signal whether or not the company can actually sell pot. The company’s third-quarter numbers came just two weeks after Canada legalized cannabis on Oct. 17, and showed they had not sold any recreational cannabis. Chief Executive Brendan Kennedy has said the fourth quarter would change all that.

Tue
19
Mar

Little pot grower that could, Indiva, looking for staff who think they can

The hiring spree at Indiva is reflective of the situation playing out at cannabis companies across the country, says the head of the largest marijuana industry association.

“This is a massively growing industry,” said Allan Rewak of the Cannabis Council of Canada, an umbrella group representing some of the country’s largest marijuana companies.

Canada’s cannabis sector employed 11,000 people in December, according to the most recent statistics available, with some projecting that number could hit 150,000 within the next decade, Rewak said.

Tue
19
Mar

4 Canadian marijuana stocks with a clinical trials research edge

Cannabis plants contain an estimated 113 cannabinoids (THC & CBD are the two that are most well known), each of which may have some medical purposes.

Companies that are spending money on clinical trials could be winners in the long run as there is potential for cannabinoids to be used as an Active Pharmaceutical Ingredient (API), as seen by the FDA approval of GW Pharmaceuticals Epidiolex, for the treatment of seizures.

However, much research still needs to be done to determine the efficacy and safety of cannabis as a medical ingredient. It typically takes a pharmaceutical company 10 years to bring a new drug onto the market.

Pages

Subscribe to RSS - Marijuana Business News